LC/MS/MS Method Package for Bile Acids
For LabSolutions™ LCMS
LC/MS/MS Method Package Bile Acids Ver. 2
Ready-to-use method for analysis of 49 Bile Acids
This Method Package allows comprehensive analysis of 49 Bile Acids from plasma, urine and feces. Bile Acids are essential for cholesterol metabolism and play a key role in absorption of fats in the small intestine. Additionally, they serve as signaling molecules that regulate metabolism. Their concentrations are used as markers of several diseases. Acute and chronic liver failure concern more than 12 million people worldwide, estimated by the World Health Organization, accounting for approximately 2 million deaths per year. Blood enzyme activity test (ALT, AST, etc.) and total bile acids assay (TBA) are widely conducted as examinations for the early diagnosis of liver diseases and liver function evaluation. More recently, monitoring of individual bile acids (IBA) was proposed for deeper pathologies characterization. However, bile acids wide structural diversity, associated with chemical similarities, leads to great challenges to analyze them.
This Method Package was developed to provide users a complete solution to perform routine analysis of selected primary, secondary and conjugates bile acids, in various matrices such as plasma, urine and feces.
- Example pretreatment protocols (including automation) for plasma, urine and feces samples,
- Robust chromatographic conditions for separation of isobaric species within a 10-min acquisition time,
- Optimized MS/MS parameters for all targeted bile acids and their conjugates (up to 3 MRM transitions),
- Optimized MS/MS parameters for 10 commercially available internal standards, covering all classes,
- Ready to use method files for LCMS-8050/8060 and LCMS-8060NX,
- Instruction manual for method installation.
News / Events
Handbook of Analysis Procedures for EPA method 533, EPA method 537.1 are now available.
The validity of the analysis performed by each laboratory needs to be confirmed by Quality Control (QC). This article section shows the general analytical procedure for fulfilling QC requirements. Note that the procedure could be modified depending on the situation in the lab and analysts.
Shimadzu has released the CLAM-2040, Fully Automated Sample Preparation Module for LCMS
The CLAM-2040 accompanies you on most of the analytical workflow and improves your overall throughput by drastically reducing the sample preparation time. Simply place the blood tubes in position and the CLAM-2040 performs the next steps automatically, from sample extraction, up to the LCMS analysis and data processing.
Per- and Polyfluoroalkyl Substances (PFAS)
Per-and polyfluoroalkyl substances (PFAS) are a group of persistent and harmful chemicals that can be commonly found in the environment globally. These anthropogenic chemicals can come from various sources such as manufacturing, industrial applications, food contact materials and consumer products, and eventually end up and accumulate in the water, soil and living organisms.
Interpretation of LC Chromatograms Facilitated by Mass Detection and the Mass-it™ Function
The LCMS-2050 mass spectrometer includes Mass-it functionality that can overlay compound mass (m/z) information, obtained with the mass spectrometer, onto UV chromatograms to support supplementing qualitative analysis results obtained using a UV detector.
Technical Background for the LCMS-2050, a Compact Mass Detector for LC
The LCMS-2050 single quadrupole mass spectrometer is highly compact in size, yet provides both high-speed and high-sensitivity analysis. Shimadzu’s technology has been condensed into an instrument miniaturized to the utmost.
Shimadzu has updated LC/MS/MS Method Package for Cell Culture Profiling Ver. 3 for LabSolutions LCMS
Version 3 of this method package adds metabolites characteristic of CHO cells, which are frequently used in the manufacture of monoclonal antibodies. Together with existing analytes, this Method Package enables the analysis of 144 compounds in under 20 minutes per sample.
3 Good health and well-being